CaridianBCT

Lakewood, United States Founded: 1964 • Age: 62 yrs Acquired By Terumo Medical
Blood transfusion products and apheresis technology are developed by CaridianBCT.

About CaridianBCT

CaridianBCT is a Healthcare company based in Lakewood (United States) founded in 1964, and was acquired by Terumo Medical in March 2011. Blood transfusion products and apheresis technology are developed by CaridianBCT. Its chief executive, as recorded, is David Perez. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Diversified. Its competitors include Aldevron, Blaze Bioscience and Meridian Bioscience; 1 of its 3 listed competitors has raised funding.

Company details

CaridianBCT was founded in 1964 and is headquartered in Lakewood, United States. Operations focus on the medical device sector, where blood processing technologies are produced for transfusion applications. Apheresis systems are utilized to separate blood into components, serving blood banks, hospitals, and biotechnology firms. Additional platforms, such as automated processing tools and pathogen inactivation methods, are maintained to support clinical and industrial needs.

Key Metrics

Investors in CaridianBCT

CaridianBCT has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include EQT and Terumo Medical.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
EQT is recognized as a global investment organization focused on value creation.
1994eqtgroup.comStockholm, Sweden
Portfolio of medical devices for interventional cardiology is provided.
1921terumo.comSomerset, United States
Premium access

Investor details for CaridianBCT

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of CaridianBCT

1 people are tracked at CaridianBCT (1 in leadership).

NameRoleGroup
David Perez
CEO & PresidentLeadership
Premium access

Complete people profiles for CaridianBCT

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of CaridianBCT

3 dated milestones of CaridianBCT across 47 years, from founding to its latest funding, stage changes and deals.

  1. Founded CaridianBCT is founded.
  2. Exit Acquired by EQT.
  3. Exit Acquired by Terumo Medical.

Competitors of CaridianBCT

CaridianBCT has 3 listed competitors in our database, 1 of them funded. They include Aldevron, Blaze Bioscience and Meridian Bioscience.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
aldevron.com1998Fargo, United States747
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
blazebioscience.com2010Seattle, United States$123.7M27
Blaze Bioscience is focused on improving cancer patient outcomes.
meridianbioscience.com1976Ohio, United States
Molecular diagnostic device and kits
Premium access

Detailed competitors of CaridianBCT

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as CaridianBCT (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about CaridianBCT

CaridianBCT was founded in 1964.

CaridianBCT is headquartered in Lakewood, United States.

David Perez is the CEO of CaridianBCT, as recorded in our data.

CaridianBCT was founded in 1964 and is headquartered in Lakewood, United States. Operations focus on the medical device sector, where blood processing technologies are produced for transfusion applications. Apheresis systems are utilized to separate blood into components, serving blood banks, hospitals, and biotechnology firms. Additional platforms, such as automated processing tools and pathogen inactivation methods, are maintained to support clinical and industrial needs.

CaridianBCT's top competitors include Meridian Bioscience, Aldevron and Blaze Bioscience.

CaridianBCT has 2 investors. Key investors include EQT, and Terumo Medical.

Yes. CaridianBCT was acquired by Terumo Medical in March 2011.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available